Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALLMARK study of aliskiren versus losartan on biomarkers of myocardial remodeling
2009-016735-36Phase 4Completed
- Sponsor
- Novartis
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in essential hypertension and left ventricular hypertrophy (LVH) comparing Aliskiren with Losartan (2 arms). Primary endpoint: Change in plasma PICP at final visit. Started Mar 2010; status: completed.
02
Drugs
aliskirenlosartan
03
Conditions
essential hypertensionleft ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on 2009-016735-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016735-36.